HistoIndex

HistoIndex, established in April 2010, is a globally leading MedTech spin-off company focusing on the research, development, manufacturing, and sales of optical medical imaging equipment, as well as providing related services for the diagnosis of fibrosis and cancer. We offer stain-free, three-dimensional, quantitative imaging solutions to display and stage fibrosis, providing crucial information that cannot be obtained by pathologists using existing staining imaging techniques. Our focus is on the accurate assessment of Nonalcoholic Steatohepatitis (NASH), a silent chronic liver disease associated with unhealthy lifestyles and metabolic syndrome. In today’s world, NASH presents a significant unmet medical need and is expected to become the leading cause of liver transplantation by 2020.